HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 118 filers reported holding HORIZON PHARMA PLC in Q3 2014. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,584,000 | +53.3% | 132,216 | +53.6% | 0.05% | +21.4% |
Q3 2018 | $1,686,000 | -13.7% | 86,091 | -37.4% | 0.04% | -33.3% |
Q1 2018 | $1,954,000 | +38.6% | 137,592 | +42.5% | 0.06% | +75.0% |
Q4 2017 | $1,410,000 | +332.5% | 96,558 | +275.9% | 0.04% | +350.0% |
Q3 2017 | $326,000 | +9.8% | 25,688 | +27.8% | 0.01% | -11.1% |
Q1 2017 | $297,000 | -82.4% | 20,100 | -80.7% | 0.01% | -79.1% |
Q4 2016 | $1,684,000 | +87.3% | 104,075 | +109.8% | 0.04% | +104.8% |
Q3 2016 | $899,000 | -25.6% | 49,605 | -32.0% | 0.02% | -32.3% |
Q1 2016 | $1,209,000 | +14.8% | 72,983 | +50.3% | 0.03% | +3.3% |
Q4 2015 | $1,053,000 | +340.6% | 48,570 | +303.5% | 0.03% | +275.0% |
Q3 2015 | $239,000 | -95.0% | 12,038 | -91.2% | 0.01% | -94.2% |
Q2 2015 | $4,773,000 | +303.8% | 137,400 | +201.9% | 0.14% | +265.8% |
Q1 2015 | $1,182,000 | -66.6% | 45,508 | -83.4% | 0.04% | -69.1% |
Q4 2014 | $3,539,000 | -2.2% | 274,577 | -6.9% | 0.12% | -6.1% |
Q3 2014 | $3,620,000 | – | 294,814 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |